Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease

Publication ,  Journal Article
Puffer, ES; Schatz, J; Roberts, CW
Published in: Child Neuropsychology
2007

Duke Scholars

Published In

Child Neuropsychology

Publication Date

2007

Volume

13

Start / End Page

142 / 154

Related Subject Headings

  • Verbal Learning
  • Retention, Psychology
  • Reaction Time
  • Operations Research
  • Neuropsychological Tests
  • Memory, Short-Term
  • Male
  • Long-Term Care
  • Hydroxyurea
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Puffer, E. S., Schatz, J., & Roberts, C. W. (2007). The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease. Child Neuropsychology, 13, 142–154.
Puffer, E. S., J. Schatz, and C. W. Roberts. “The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease.” Child Neuropsychology 13 (2007): 142–54.
Puffer ES, Schatz J, Roberts CW. The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease. Child Neuropsychology. 2007;13:142–54.
Puffer, E. S., et al. “The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease.” Child Neuropsychology, vol. 13, 2007, pp. 142–54.
Puffer ES, Schatz J, Roberts CW. The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease. Child Neuropsychology. 2007;13:142–154.

Published In

Child Neuropsychology

Publication Date

2007

Volume

13

Start / End Page

142 / 154

Related Subject Headings

  • Verbal Learning
  • Retention, Psychology
  • Reaction Time
  • Operations Research
  • Neuropsychological Tests
  • Memory, Short-Term
  • Male
  • Long-Term Care
  • Hydroxyurea
  • Humans